chrX-15822802-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_005089.4(ZRSR2):āc.1009A>Gā(p.Asn337Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000134 in 1,211,076 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 54 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00012 ( 0 hom., 4 hem., cov: 24)
Exomes š: 0.00013 ( 0 hom. 50 hem. )
Consequence
ZRSR2
NM_005089.4 missense
NM_005089.4 missense
Scores
1
6
10
Clinical Significance
Conservation
PhyloP100: 9.02
Genes affected
ZRSR2 (HGNC:23019): (zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2) This gene encodes an essential splicing factor. The encoded protein associates with the U2 auxiliary factor heterodimer, which is required for the recognition of a functional 3' splice site in pre-mRNA splicing, and may play a role in network interactions during spliceosome assembly. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZRSR2 | NM_005089.4 | c.1009A>G | p.Asn337Asp | missense_variant | 11/11 | ENST00000307771.8 | NP_005080.1 | |
ZRSR2 | XM_011545589.4 | c.1078A>G | p.Asn360Asp | missense_variant | 10/10 | XP_011543891.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZRSR2 | ENST00000307771.8 | c.1009A>G | p.Asn337Asp | missense_variant | 11/11 | 1 | NM_005089.4 | ENSP00000303015.7 | ||
ZRSR2 | ENST00000684799.1 | c.931A>G | p.Asn311Asp | missense_variant | 10/11 | ENSP00000510773.1 | ||||
ZRSR2 | ENST00000690252.1 | n.1009A>G | non_coding_transcript_exon_variant | 11/13 | ENSP00000510140.1 | |||||
ZRSR2 | ENST00000691502.1 | n.938-43A>G | intron_variant | ENSP00000509336.1 |
Frequencies
GnomAD3 genomes AF: 0.000124 AC: 14AN: 112807Hom.: 0 Cov.: 24 AF XY: 0.000114 AC XY: 4AN XY: 34943
GnomAD3 genomes
AF:
AC:
14
AN:
112807
Hom.:
Cov.:
24
AF XY:
AC XY:
4
AN XY:
34943
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000381 AC: 7AN: 183520Hom.: 0 AF XY: 0.0000442 AC XY: 3AN XY: 67946
GnomAD3 exomes
AF:
AC:
7
AN:
183520
Hom.:
AF XY:
AC XY:
3
AN XY:
67946
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000135 AC: 148AN: 1098269Hom.: 0 Cov.: 32 AF XY: 0.000138 AC XY: 50AN XY: 363623
GnomAD4 exome
AF:
AC:
148
AN:
1098269
Hom.:
Cov.:
32
AF XY:
AC XY:
50
AN XY:
363623
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000124 AC: 14AN: 112807Hom.: 0 Cov.: 24 AF XY: 0.000114 AC XY: 4AN XY: 34943
GnomAD4 genome
AF:
AC:
14
AN:
112807
Hom.:
Cov.:
24
AF XY:
AC XY:
4
AN XY:
34943
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2024 | The c.1009A>G (p.N337D) alteration is located in exon 11 (coding exon 11) of the ZRSR2 gene. This alteration results from a A to G substitution at nucleotide position 1009, causing the asparagine (N) at amino acid position 337 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
M_CAP
Uncertain
D
MetaRNN
Uncertain
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at